Russia's Vektor - a top-secret state virology research centre in Siberia - said that early-stage trials were successful for its own experimental vaccine, named EpiVacCorona. "The first two phases of clinical trials demonstrated the effectiveness and safety of the EpiVacCorona vaccine," Vektor's press department told the Interfax news agency.from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/2SiDPGZ
Second Russian virus vaccine passes early trials: Report
![Second Russian virus vaccine passes early trials: Report]()
Reviewed by us4
on
October 01, 2020
Rating:
No comments: